2095 POSTER A randomized, open-label CECOG phase II study of dose-dense FEC 75 vs FEC 90 as adjuvant therapy in early breast cancer patients

✍ Scribed by S. Kahan; S. Spanik; M. Wagnerova; T. Skacel; B. Planko; E. Fitzthum; E. Lindner; V. Soldatenkova; C.C. Zielinski; T. Brodowicz

• Book ID: 118625699
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 78 KB
• Volume: 5
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(07)70857-1